New metal complexes of NNO tridentate ligands: Effect of metal center and co-ligand on biological activity

被引:23
作者
Machado, I. [1 ]
Fernandez, M. [1 ]
Becco, L. [2 ]
Garat, B. [2 ]
Brissos, R. F. [3 ]
Zabarska, N. [3 ]
Gamez, P. [3 ,4 ]
Marques, F. [5 ]
Correia, I. [6 ]
Costa Pessoa, J. [6 ]
Gambino, D. [1 ]
机构
[1] Univ Republica, Fac Quim, DEC, Montevideo 11800, Uruguay
[2] Univ Republica, Fac Ciencias, Lab Interacc Mol, Montevideo 11400, Uruguay
[3] Univ Barcelona, Dept Quim Inorgan, QBI, E-08028 Barcelona, Spain
[4] ICREA, Barcelona 08010, Spain
[5] Inst Super Tecn, Unidade Ciencias Quim & Radiofarmaceut, P-2695066 Bobadela Lrs Sacavem, Portugal
[6] Univ Tecn Lisboa, Inst Super Tecn, Ctr Quim Estrutural, P-1049001 Lisbon, Portugal
关键词
Oxidovanadium(IV) and dioxidovanadium(V) complexes; Gallium(III); N; O ligands; Antitrypanosomal; Antitumoral; TRYPANOSOMA-CRUZI; SPECTROSCOPIC PROPERTIES; VANADIUM COMPLEXES; CYTOTOXIC ACTIVITY; ANTITUMOR AGENTS; PT(II) COMPLEXES; CANCER-TREATMENT; CHAGAS-DISEASE; DRUGS; CRYSTAL;
D O I
10.1016/j.ica.2013.10.022
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
In the search for new agents against Ttypanosoma cruzi and cancer the effect of the nature of the metal center and of the presence of a polypiridyl coligand on the antitrypanosomal and antitumoral activities of selected N,N,O ligands [2-(benzothiazol-2-yl hydrazonomethyl phenol (HL1) and 2-(benzothiazol-2-yl-hydrazonomethyl)-6-methoxyphenol (HL2)] is explored. The new complexes [(VO2)-O-V(L1)I, [(VO2)-O-V(L2)], [(VO)-O-IV(L1-H)(phen))] and [Ga-III(L2)(2)](NO3) were synthesized and characterized by using different techniques. The stability of the vanadium complexes in solution was investigated by EPR and V-51 NMR spectroscopies and that of the gallium compound by UV-Vis spectroscopy, H-1 NMR and conductivity measurements. While the vanadium complexes show high stability in DMSO, the gallium complex shows very good stability in DMSO and moderate stability in aqueous - DMSO medium. The cytotoxicity on human tumor cell lines (ovarian A2780, breast MCF7 and prostate PC3 cell lines) that show different sensitivity to cisplatin was evaluated. All the compounds evidenced antiproliferative activity in the micromolar range. The highest cytotoxic activity, in molar units, is shown by [Ga-III(L2)(2)](-NO3) (IC50: 1.7 mu M) and [(VO)-O-IV(L1-H)(phen)] (IC50: 2.7 mu M) against the ovarian cancer cells. With the exception of [(VO2)-O-V(L1)], the cytotoxic activity of the ligands and complexes is similar to that of cisplatin in A2780 cells and surpass cisplatin in the other tumor cells. Regarding the activity on T. cruzi, [(VO)-O-IV(L1-H)(phen)] showed a 10-fold decrease of IC50 with respect to HL1 and an IC50 value (10.7 mu M) in the same order of that of the antitrypanosomal drug Nifurtimox (IC50: 6.0 mu M). HL2 showed significant growth inhibitory effect on the parasite (IC50: 23.5 mu M) and its coordination to Ga(III) lead to a 2-fold increase in activity in molar units (IC50: 14.2 mu M). In order to explain the high inhibitory activity of [(VO)-O-IV(L1-H)(phen)] against the parasite and the tumor cells, the interaction of this compound with plasmid DNA was preliminarily evaluated by AFM. The corresponding images suggest that DNA may be considered as a potential target. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 57 条
[1]  
[Anonymous], 1981, Biol. Magn. Reson., DOI DOI 10.1007/978-1-4613-3201-52
[2]  
Baran EJ, 2008, LAT AM J PHARM, V27, P776
[3]   New achievements on biological aspects of copper complexes Casiopeinas®: Interaction with DNA and proteins and anti-Trypanosoma cruzi activity [J].
Becco, Lorena ;
Rodriguez, Alejandra ;
Elena Bravo, Maria ;
Jose Prieto, Maria ;
Ruiz-Azuara, Lena ;
Garat, Beatriz ;
Moreno, Virtudes ;
Gambino, Dinorah .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 109 :49-56
[4]   Searching for Vanadium-Based Prospective Agents against Trypanosoma cruzi: Oxidovanadium(IV) Compounds with Phenanthroline Derivatives as Ligands [J].
Benitez, Julio ;
Correia, Isabel ;
Becco, Lorena ;
Fernandez, Mariana ;
Garat, Beatriz ;
Gallardo, Hugo ;
Conte, Gilmar ;
Kuznetsov, Maxim L. ;
Neves, Ademir ;
Moreno, Virtudes ;
Pessoa, Joao Costa ;
Gambino, Dinorah .
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, 2013, 639 (8-9) :1417-1425
[5]   New oxidovanadium(IV) N-acylhydrazone complexes: Promising antileishmanial and antitrypanosomal agents [J].
Benitez, Julio ;
de Queiroz, Aline Cavalcanti ;
Correia, Isabel ;
Alves, Marina Amaral ;
Alexandre-Moreira, Magna S. ;
Barreiro, Eliezer J. ;
Lima, Lidia Moreira ;
Varela, Javier ;
Gonzalez, Mercedes ;
Cerecetto, Hugo ;
Moreno, Virtudes ;
Pessoa, Joao Costa ;
Gambino, Dinorah .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :20-27
[6]   Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: New achievements [J].
Benitez, Julio ;
Becco, Lorena ;
Correia, Isabel ;
Milena Leal, Sandra ;
Guiset, Helena ;
Pessoa, Joao Costa ;
Lorenzo, Julia ;
Tanco, Sebastian ;
Escobar, Patricia ;
Moreno, Virtudes ;
Garat, Beatriz ;
Gambino, Dinorah .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2011, 105 (02) :303-312
[7]   New trends for metal complexes with anticancer activity [J].
Bruijnincx, Pieter C. A. ;
Sadler, Peter J. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) :197-206
[8]   N-SALICYLIDENEAMINO ACIDATE COMPLEXES OF OXOVANADIUM(IV) .1. CRYSTAL AND MOLECULAR-STRUCTURES AND SPECTROSCOPIC PROPERTIES [J].
CAVACO, I ;
PESSOA, JC ;
COSTA, D ;
DUARTE, MT ;
GILLARD, RD ;
MATIAS, P .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1994, (02) :149-157
[9]   Crystal and molecular structure of [V2O3(sal-L-val)(2)(H2O)] (sal-L-val equals N-salicylidene-L-valinate) and spectroscopic properties of related complexes [J].
Cavaco, I ;
Pessoa, JC ;
Duarte, MT ;
Henriques, RT ;
Matias, PM ;
Gillard, RD .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1996, (09) :1989-1996
[10]   Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania [J].
Cavalli, Andrea ;
Bolognesi, Maria Laura .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) :7339-7359